Generic giant Teva Pharmaceuticals will launch the first generic version of Victoza (liraglutide injection 1.8mg) in the U.S, making it the first generic GLP-1 drug to enter the U.S
lactis HN019 alone, at a dose of 10 billion CFUs per day, for 28 days increased stool frequency and reduced straining in a subgroup of those reporting three or fewer bowel movements per week at baseline (Ibarra 2018)
Book a free consult to determine eligibility
In my previous Substack posts, we've unpacked the transformative power of GLP-1 medicationshow they work, why they're so effective against obesity, and how physicians like myself carefully use them off-label to tackle metabolic dysfunction at its core
The decision affected both individual marketplace plans and small group employer coverage
A practical stack is 2 to 3 grams of each taken 60 minutes before training